These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Soluble immunological parameters and early prognosis of renal cell cancer patients. Kallio JP; Tammela TL; Marttinen AT; Kellokumpu-Lehtinen PL J Exp Clin Cancer Res; 2001 Dec; 20(4):523-8. PubMed ID: 11876546 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of serum biological markers in patients with hepatocellular carcinoma. Parasole R; Izzo F; Perrone F; Pignata S; Galati MG; Leonardi E; Castiglione F; Orlando R; Castello G; Esposito G; Gallo C; Daniele B Clin Cancer Res; 2001 Nov; 7(11):3504-9. PubMed ID: 11705869 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma. Yamada M; Yanaba K; Takehara K; Sato S Arch Dermatol Res; 2005 Dec; 297(6):256-60. PubMed ID: 16222535 [TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma]. Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038 [TBL] [Abstract][Full Text] [Related]
7. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer. Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of interleukins 2, 6 and 8, soluble interleukin-2 receptor and intercellular adhesion molecule-1 during treatment with interleukin-2 plus interferon-alfa. Vuoristo MS; Kellokumpu-Lehtinen P; Laine S; Soppi E Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):337-54. PubMed ID: 8872489 [TBL] [Abstract][Full Text] [Related]
9. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery]. Tsukamoto S; Ishikawa S; Yamauchi A; Saitou S Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193 [TBL] [Abstract][Full Text] [Related]
10. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer. Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of specific IgE, soluble interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in seasonal allergic rhinitis. Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M Ann Allergy Asthma Immunol; 1997 Sep; 79(3):213-20. PubMed ID: 9305226 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous measurement of circulating intercellular adhesion molecule-1 and serum copper zinc superoxide dismutase activity in patients with malignant melanoma. Wollina U; Karte K; Olbertz K; Hipler UC Oncol Rep; 1998; 5(2):473-6. PubMed ID: 9468582 [TBL] [Abstract][Full Text] [Related]
13. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma]. Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970 [TBL] [Abstract][Full Text] [Related]
14. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus. Srivastava MD; Rossi TM; Lebenthal E Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726 [TBL] [Abstract][Full Text] [Related]
15. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Bosserhoff AK; Kaufmann M; Kaluza B; Bartke I; Zirngibl H; Hein R; Stolz W; Buettner R Cancer Res; 1997 Aug; 57(15):3149-53. PubMed ID: 9242442 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in patients with stage III and IV non-small cell lung cancer]. Song LH; Song XR; Liu MQ; Zhang XQ; Zheng L; Li XJ; Liu PX Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):345-8. PubMed ID: 15312344 [TBL] [Abstract][Full Text] [Related]
17. Elevated levels of interleukin-2 receptor and intercellular adhesion molecule 1 in sera from a venezuelan cohort of patients with dengue. Valero N; Larreal Y; Espina LM; Reyes I; Maldonado M; Mosquera J Arch Virol; 2008; 153(1):199-203. PubMed ID: 18080798 [TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors. Gebauer G; Rieger M; Jäger W; Lang N Anticancer Res; 1999; 19(4A):2509-11. PubMed ID: 10470184 [TBL] [Abstract][Full Text] [Related]
19. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma]. Setoyama Y; Imai J; Ishikawa T; Sakaida H; Takaori-Kondo A; Kawamata S; Uchiyama T Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620 [TBL] [Abstract][Full Text] [Related]
20. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus. Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]